HUMAN ANTIBODIES THAT BIND TO HUMAN IL-12 AND METHODS FOR PRODUCING THE SAME

PROBLEM TO BE SOLVED: To provide human antibodies, preferably recombinant human antibodies, that specifically bind to human interleukin-12 (hIL-12).SOLUTION: A preferred antibody has a high affinity for hIL-12 and neutralize hIL-12 activity in vitro and in vivo. An antibody of the invention can be a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: VENTURINI AMY, TRACEY DANIEL E, KAYMAKCALAN ZEHRA, VELDMAN GEERTRUIDA M, WIDOM ANGELA, DUNCAN ALEXANDER R, WHITE MICHAEL, SMITH STEPHEN, SAKORAFAS PAUL, DU FOU SARAH L, SALFELD JOCHEN G, MYLES ANGELA, FRIEDRICH STUART, ROGUSKA MICHAEL, ELVIN JOHN G, PASKIND MICHAEL, LABKOVSKY BORIS, DERBYSHIRE ELAINE J, BANERJEE SUBHASHIS, WARNE NICHOLAS W, CARMEN SARA, HOLTET THOR LAS
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:PROBLEM TO BE SOLVED: To provide human antibodies, preferably recombinant human antibodies, that specifically bind to human interleukin-12 (hIL-12).SOLUTION: A preferred antibody has a high affinity for hIL-12 and neutralize hIL-12 activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibody or an antibody portion thereof is useful, e.g., for detecting hIL-12 and for inhibiting hIL-12 activity in a human subject suffering from a disorder in which hIL-12 activity is identified. There are provided a nucleic acid for a recombinant human antibody expression, a vector, a host cell, and a synthetic process of a recombinant human antibody.